Reach Neuro, Inc.

It’s time for the March edition of our MedTech Startup Spotlight series! 1st Place Winner of NEMIC's 2024 Fall Pitch Competition and featured most recently in the inaugural 2025 RI Life Science Hub #NeuroscienceSymposium,?Reach Neuro?is?an innovative company with Rhode Island ties that is revolutionizing medicine with the world’s first treatment of chronic stroke.?Reach Neuro, Inc. has developed a breakthrough technology to directly restore hand, arm, and shoulder movement for stroke survivors.?Utilizing dorsal root stimulation, an implanted device targets the spinal cord, thus allowing brain control of the limb to be regained. To learn more about how Reach Neuro is transforming the lives of those living with chronic stroke, check out the?NEMIC Blog: https://lnkd.in/eu_PcwZH Marc Powell #ReachNeuro #NEMIC #Neuroscience #Stroke #ChronicStroke #StartupSpotlight #RILSH #MedTech #HealthTech #HealthcareInnovation

LifeX Ventures is thrilled to welcome Reach Neuro, Inc. to our portfolio. This neurotechnology startup is revolutionizing stroke rehabilitation by developing innovative spinal cord stimulation therapies to restore movement in stroke survivors. Using an electrode array implanted in the cervical spinal cord, Reach Neuro delivers precise electrical pulses to reawaken the nervous system, helping patients regain control over their shoulder, arm, and hand—and ultimately, their independence. With the FDA’s Breakthrough Device designation and NIH-funded clinical trials, Reach Neuro is poised to transform care for millions affected by stroke-related disabilities. As a spinout of the University of Pittsburgh and Carnegie Mellon University, their strong academic foundation further solidifies their path to success. Welcome to the LifeX family, Reach Neuro—we can’t wait to see the impact you’ll make! Learn more:?https://reachneuro.com/ #LifeXVentures #Neurotechnology #StrokeRehabilitation #HealthcareInnovation #BreakthroughDevice #lifesciences #LifeX #LifeScienceStartups #PittsburghInnovation #LifeXAccelerator

Hot off the press! The latest edition of The Memo, featuring Marc Powell, Co-Founder & CEO of Reach Neuro, Inc. is out now! Under the direction of Co-Founder and CEO Marc Powell, Reach Neuro is transforming the treatment landscape for chronic stroke patients with its groundbreaking spinal cord stimulation technology. This innovation—designed to restore volitional movement in individuals with long-term motor deficits—offers hope to millions of patients who have plateaued in traditional rehabilitation and face a lack of viable treatment options. Read the full story: https://lnkd.in/gAs6ZdzW

Attention all my?neuroscience friends and colleagues at?SfN this?year!???? In recent years there have been exciting advances in the development of implantable BCIs for controlling computers and other external devices. But for many with tetraplegia, the ultimate goal of restoring natural arm and hand function is still far from realized. This year at the Society for Neuroscience (SfN) conference, Sarah Kim Wandelt and I organized a nanosymposium to convene talks on emerging #neurotech approaches for restoring movement, including functional electrical stimulation (FES), spinal cord stimulation (SCS), and my PhD work with BrainGate Team combining iBCI decoding with soft robotic wearables. We invite you to drop by, connect, and engage with this highly interdisplinary topic that holds the promise of transforming lives for those affected by upper-limb paralysis. ?????????????? ??????????????: ? ??????????: "Neuroprosthetic Strategies for Upper Limb Recovery" ? ????????: Tuesday, October 8th ? ????????: 1:00 PM - 3:15 PM ? ????????????????: MCP Room S401 ????????????????????: Jake Gusman, Kushaal Rao, Marc Powell, Nikhil Verma, John Krall, Sarah Wandelt, Nabila Shawki, Thibault Collin, Santosh Chandrasekaran #SfN2024 #Neuroprosthetics #BrainGate #PhDResearch #BCIs #SpinalCordInjury #ALS